Suven Life finalizes phase I trial for Alzheimer drug

May 18, 2011 at 8:07 PM

Suven Life finished phase I clinical trial of Suvn-502, a new chemical unit for Alzheimer’s disease cure, and told that it is submitting files for Investigational New Drug application with the US Food and Drug Administration.

Labels:

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)